India Contraceptives Market Investigated in New Pharmaion Consultants Report Recently Published at MarketPublishers.com
18 Mar 2016 • by Natalie Aster
LONDON – The Indian total population surged from 359 million in 1950 to 1238.9 million people by 2014-end. India represents around 18% of the world’s total population, implying that every sixth person on earth is an Indian. All these statistical figures call for the implementation of population control measures, which has been giving a boost to demand for safe and efficient contraceptive devices and drug products across the country. Additionally, option to have long-term contraception, ease of use, lesser amount of negative side effects and the ability of few devices to prevent sexually transmitted diseases (STDs) are amid the other essential factors contributing to the expansion of the Indian contraceptives marketplace.
Bayer Zydus Pharma Pvt. Ltd., HLL Lifecare Limited, Cupid Ltd., JK Ansell Ltd., MSD India, Piramal Enterprises Ltd., Mankind Pharma Ltd., Pfizer Ltd., Pregna International Ltd. and RB India are the dominant players in the contraceptives market place.
New research report “India Contraceptives Market Opportunities, 2011 - 2021” developed by Pharmaion Consultants draws up an all-round analysis of the national contraceptives market. It canvasses the market size and share of different segments and sub-segments of the domestic contraceptives market. The report categorises the market into two broader segments, encompassing contraceptive drugs and contraceptive devices. The research publication accurately investigates the factors that are fuelling the market alongside the challenges propelling the growth of the sector. The publication gives keen insights into the major market trends and emerging opportunities; offers import and export analysis; gives a comprehensive analysis of the ever-changing competitive scenario; India’s economic profile; and detailed revenue projections for each of the market segments and sub-segments. An in-depth analysis of the policy and regulatory landscape is included. It also provides a detailed examination of the competitive scene in the industry alongside profiling the top 10 players, as well as offers strategic recommendations.
India Contraceptives Market Opportunities, 2011 - 2021
Published: March, 2015
Price: US$ 2,500.00
More studies by this publisher are available at Pharmaion Consultants page.